• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neurocrine Bioscienc (NQ: NBIX )

    152.27 -0.54 (-0.35%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 490,805
    Open 153.13
    Bid (Size) 144.42 (1)
    Ask (Size) 158.00 (1)
    Prev. Close 152.81
    Today's Range 151.70 - 154.00
    52wk Range 103.63 - 157.98
    Shares Outstanding 100,900,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why the quality investor may take a look at NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
    Is NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) suited for quality investing? 
    Via Chartmill
    Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
    Via Benzinga

    Performance

    YTD
    +15.59%
    +15.59%
    1 Month
    +3.73%
    +3.73%
    3 Month
    +8.39%
    +8.39%
    6 Month
    +12.31%
    +12.31%
    1 Year
    +42.47%
    +42.47%

    More News

    Read More
    NASDAQ:NBIX—A High-Growth Stock Gearing Up for Its Next Upward Move.
    Via Chartmill
    NASDAQ:NBIX is not too expensive for the growth it is showing.
    Via Chartmill
    9 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    New Study Reveals How Classical Music Could Revolutionize Depression Care
    Via PressReach
    Exposures Product Safety
    A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
    Via Benzinga
    So Much For Expecting The Fed To Stick The Landing
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
    Via Investor's Business Daily
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
    Via Chartmill
    NASDAQ:NBIX, a growth stock which is not overvalued.
    Via Chartmill
    Should Quality Investors Include NASDAQ:NBIX in Their Portfolio?
    Via Chartmill
    Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
    Via Benzinga
    Key Takeaways From Neurocrine Biosciences Analyst Ratings
    Via Benzinga
    Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation.
    Via Chartmill
    NASDAQ:NBIX is not too expensive for the growth it is showing.
    Via Chartmill
    Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.
    Via Chartmill
    Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued.
    Via Chartmill
    7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
    Via InvestorPlace
    Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
    Via Chartmill
    Exploring NASDAQ:NBIX's quality characteristics.
    Via Chartmill
    Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
    Via Chartmill
    In the world of growth stocks, NASDAQ:NBIX shines as a value proposition.
    Via Chartmill
    Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
    Via Investor's Business Daily
    Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
    Via Chartmill
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.